OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study
Haoran Xia, Han Zhang, Zheng Ruan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Haoran Xia, Han Zhang, Zheng Ruan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
Yilv Yan, Dongqing Sun, Junjie Hu, et al.
Nature Genetics (2024)
Closed Access | Times Cited: 7
Yilv Yan, Dongqing Sun, Junjie Hu, et al.
Nature Genetics (2024)
Closed Access | Times Cited: 7
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial
Liang Zeng, Huan Yan, Wenjuan Jiang, et al.
Med (2025), pp. 100574-100574
Closed Access
Liang Zeng, Huan Yan, Wenjuan Jiang, et al.
Med (2025), pp. 100574-100574
Closed Access
Longitudinal relationship between posttraumatic growth and distress in lung cancer patients during neoadjuvant immunotherapy
Qiao Chu, Fenghuan Sun, Xinsheng Zhu, et al.
International Journal of Clinical and Health Psychology (2025) Vol. 25, Iss. 1, pp. 100549-100549
Open Access
Qiao Chu, Fenghuan Sun, Xinsheng Zhu, et al.
International Journal of Clinical and Health Psychology (2025) Vol. 25, Iss. 1, pp. 100549-100549
Open Access
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives
Lucrezia Barcellini, Simone Nardin, G. Sacco, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 652-652
Open Access
Lucrezia Barcellini, Simone Nardin, G. Sacco, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 652-652
Open Access
A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review
Ping Song, Yuqi Jin, Lifang Dai, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Ping Song, Yuqi Jin, Lifang Dai, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial
Dongliang Bian, Shuyu Ji, Yue Liu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Dongliang Bian, Shuyu Ji, Yue Liu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Neoadjuvant Camrelizumab Plus Chemotherapy or Apatinib for Resectable Stage IIA-IIIA NSCLC: A Multicenter, Two-Arm, Phase II Exploratory Trial
Shuyu Ji, Zhenxin Sheng, Dongliang Bian, et al.
Research Square (Research Square) (2025)
Closed Access
Shuyu Ji, Zhenxin Sheng, Dongliang Bian, et al.
Research Square (Research Square) (2025)
Closed Access
scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer
Ziqi Huang, Li Li, Xiaohe Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Ziqi Huang, Li Li, Xiaohe Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
An axis involving TPX2/hsa-let-7b-5p/TMPO-AS1 promotes lung adenocarcinoma in smokers
Rajeev Nema
Oncology in Clinical Practice (2024)
Open Access
Rajeev Nema
Oncology in Clinical Practice (2024)
Open Access
Neoadjuvant immunotherapy for non-small cell lung cancer: Opportunities and challenges
Junjie Hu, Jing Zhang, Shiyue Wan, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 4, pp. 224-239
Open Access
Junjie Hu, Jing Zhang, Shiyue Wan, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 4, pp. 224-239
Open Access
